| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.468 | 21.685 | 34.133 | 31.773 | 53.053 | 67.090 | 111.405 | 116.505 | 127.381 | 138.621 |
| Total Income - EUR | 19.468 | 21.685 | 34.133 | 31.787 | 53.059 | 67.092 | 119.007 | 123.325 | 127.382 | 138.725 |
| Total Expenses - EUR | 16.372 | 9.881 | 16.253 | 16.416 | 24.736 | 35.561 | 49.608 | 47.004 | 60.177 | 68.202 |
| Gross Profit/Loss - EUR | 3.097 | 11.804 | 17.880 | 15.370 | 28.324 | 31.531 | 69.398 | 76.321 | 67.205 | 70.522 |
| Net Profit/Loss - EUR | 2.512 | 11.153 | 17.455 | 15.052 | 27.793 | 30.860 | 68.285 | 74.802 | 66.318 | 68.357 |
| Employees | 1 | 1 | 2 | 2 | 1 | 0 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Trans Cogen Medical Company Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.591 | 0 | 0 | 0 | 0 | 17.952 | 26.994 | 47.786 | 70.187 | 63.077 |
| Current Assets | 14.342 | 21.986 | 29.032 | 32.534 | 35.801 | 62.162 | 126.117 | 64.940 | 136.791 | 118.297 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 946 | 0 | 892 | 2.836 | 362 |
| Receivables | 1.021 | 2.732 | 815 | 5.671 | 24.210 | 21.923 | 107.385 | 57.214 | 116.999 | 45.428 |
| Cash | 13.321 | 19.254 | 28.217 | 26.864 | 11.591 | 39.293 | 18.732 | 6.834 | 16.956 | 72.507 |
| Shareholders Funds | 3.542 | 3.506 | 3.447 | 3.383 | 31.111 | 61.381 | 128.304 | 77.995 | 144.076 | 130.716 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 13.391 | 18.480 | 25.585 | 29.151 | 4.690 | 18.733 | 24.806 | 34.731 | 62.868 | 50.623 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35 | 35 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Trans Cogen Medical Company Srl